Cited by 1,091Autophagy in Disease and TherapyPI3K/AKT/mTOR signaling in cancerAlzheimer's disease research and treatments

The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration

Heras-Sandoval, David, Pérez-Rojas, Jazmin M., Hernández-Damián, Jacqueline, Pedraza-Chaverri, José·2014·Cellular Signalling

Abstract

Disruption of autophagy plays an import role in neurodegenerative disorders, where deficient elimination of abnormal and toxic protein aggregates promotes cellular stress, failure and death. Therefore, induction of autophagy has been proposed as a reasonable strategy to help neurons clear abnormal protein aggregates and survive. The kinase mammalian target of rapamycin (mTOR) is a major regulator of the autophagic process and is regulated by starvation, growth factors, and cellular stressors. Upstream of mTOR the survival PI3K/AKT pathway modulates mTOR activity that is also altered in neurodegenerative diseases of Alzheimer and Parkinson. Nevertheless, the interplay between the PI3K/AKT/mTOR pathway and the autophagic process is complex and a more detailed examination of tissue from patients suffering neurodegenerative diseases and of animal and cellular models is needed. In the present work we review the recent findings on the role of the PI3K/AKT/mTOR pathway in the modulation of the autophagic process in neuronal protection.

Integrity signals

Registry

Crossref · 10.1016/j.cellsig.2014.08.019

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Enhancing autophagy has previously been explored as a strategy to modulate neurodegeneration disease progression but with a focus on autophagic degradation of proteins, as opposed to autophagic degradation of intracellular LDs (lipophagy).

    “Enhancing autophagy has previously been explored as a strategy to modulate neurodegeneration disease progression but with a focus on autophagic degradation of proteins41, as opposed to the autophagic degradation of intracellular LDs (lipophagy).”
  • Molecular and histopathologic analyses of patient tissues demonstrate mislocalized or accumulated autophagy machinery, pathogenic mutations underlying familial neurodegenerative diseases disable known autophagy-related factors, and genetically ablating autophagy effectors produces neurodegeneration in cell and animal model systems, supporting a role for autophagy dysfunction in age-related neurode

    “Molecular and histopathologic analyses of patient tissues demonstrate mislocalized or accumulated autophagy machinery, pathogenic mutations underlying familial neurodegenerative diseases disable known autophagy-related factors, and genetically ablating autophagy effectors produce neurodegeneration in cell and animal model systems [74–81], supporting a role for autophagy dysfunction in the devel”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Heras-Sandoval, D., Pérez-Rojas, J. M., Hernández-Damián, J., & Pedraza-Chaverri, J.
Affiliations
Universidad Nacional Autónoma de México (MX)
Venue
Cellular Signalling
Publisher
Elsevier BV
Published
2014-12
Volume
26
Issue
12
Pages
2694-2701
ISSN
0898-6568 (ISSN-L)
OpenAlex
W2071466153
Cited by
1,091
References
108
Citations by year
2026: 42 · 2025: 97 · 2024: 115 · 2023: 101 · 2022: 113 · 2021: 132 · 2020: 114 · 2019: 116 · 2018: 96 · 2017: 73 · 2016: 41 · 2015: 42 · 2014: 5 · 2013: 1
FWCI
7.16
Type
journal article
Language
en
Open access
closed
Locations
  • Cellular Signalling (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • DGAPA-UNAM
  • PAPIIT (IN210713)
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
PI3K/AKT/mTOR pathway, autophagy, protein aggregates, neurodegeneration, mTOR, neuronal survival, Alzheimer's disease, Parkinson's disease, autophagy regulation, cellular stress
MeSH terms
Animals, Autophagy, Humans, Neurons, Signal Transduction, Neurodegenerative Diseases, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases, Protein Aggregates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review